WO2007143143A3 - Composition servant à accroître la récupération musculaire - Google Patents

Composition servant à accroître la récupération musculaire Download PDF

Info

Publication number
WO2007143143A3
WO2007143143A3 PCT/US2007/013026 US2007013026W WO2007143143A3 WO 2007143143 A3 WO2007143143 A3 WO 2007143143A3 US 2007013026 W US2007013026 W US 2007013026W WO 2007143143 A3 WO2007143143 A3 WO 2007143143A3
Authority
WO
WIPO (PCT)
Prior art keywords
component
protein
preparations
carbohydrate
composition
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
PCT/US2007/013026
Other languages
English (en)
Other versions
WO2007143143A2 (fr
Inventor
Robert Portman
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
PacificHealth Laboratories Inc
Original Assignee
PacificHealth Laboratories Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by PacificHealth Laboratories Inc filed Critical PacificHealth Laboratories Inc
Publication of WO2007143143A2 publication Critical patent/WO2007143143A2/fr
Publication of WO2007143143A3 publication Critical patent/WO2007143143A3/fr
Anticipated expiration legal-status Critical
Ceased legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K35/20—Milk; Whey; Colostrum
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/17—Amino acids, peptides or proteins
    • A23L33/175—Amino acids
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/17—Amino acids, peptides or proteins
    • A23L33/19—Dairy proteins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7004—Monosaccharides having only carbon, hydrogen and oxygen atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/02—Peptides of undefined number of amino acids; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/1703—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • A61K38/1709—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Engineering & Computer Science (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Molecular Biology (AREA)
  • Immunology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Mycology (AREA)
  • Nutrition Science (AREA)
  • Food Science & Technology (AREA)
  • Polymers & Plastics (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Marine Sciences & Fisheries (AREA)
  • Biomedical Technology (AREA)
  • Biotechnology (AREA)
  • Cell Biology (AREA)
  • Developmental Biology & Embryology (AREA)
  • Virology (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

Abstract

L'invention concerne une composition essentielle qui sert à prévenir ou à retarder la perte de force musculaire et l'atrophie au cours de périodes prolongées d'inactivité. Les compositions sont caractérisées par une proportion de glucides par rapport aux protéines allant d'environ 1,5:1 à 2:1 et par la présence d'un composant acide aminé spécifique de leucine et, de façon optimale, d'arginine. Le composant glucide est constitué d'au moins deux éléments d'un groupe de quatre sucres et le composant protéine est constitué d'une protéine de lactosérum et de caséine. Un composant glucide préféré est constitué de glucose et de saccharose. La proportion de protéine de lactosérum par rapport à la caséine dans les compositions de l'invention est d'environ 3:1. Les compositions de l'invention sont de préférence sous forme de préparations contenant des matières excipients classiques telles que des arômes, des agents colorants, des émulsifiants, des édulcorants de synthèse et similaires, de telles préparations représentant d'environ 33 à 58 grammes de la composition essentielle, laquelle comprend d'environ 15 % à 80 % en poids desdites préparations.
PCT/US2007/013026 2006-05-31 2007-05-31 Composition servant à accroître la récupération musculaire Ceased WO2007143143A2 (fr)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US11/444,177 US20070280997A1 (en) 2006-05-31 2006-05-31 Composition for enhancing muscle recovery
US11/444,177 2006-05-31

Publications (2)

Publication Number Publication Date
WO2007143143A2 WO2007143143A2 (fr) 2007-12-13
WO2007143143A3 true WO2007143143A3 (fr) 2008-02-21

Family

ID=38790512

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/US2007/013026 Ceased WO2007143143A2 (fr) 2006-05-31 2007-05-31 Composition servant à accroître la récupération musculaire

Country Status (2)

Country Link
US (1) US20070280997A1 (fr)
WO (1) WO2007143143A2 (fr)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2009018166A1 (fr) * 2007-07-27 2009-02-05 Nutritional Network, Inc. Formulations de performance d'exercice et de récupération post-exercice
US20090074936A1 (en) * 2007-09-17 2009-03-19 Schmidt James C Energy beverage
RU2375923C2 (ru) * 2008-01-18 2009-12-20 ЗАО "Академия-Т" Специализированный белковый продукт для питания спортсменов
EP2493325B1 (fr) * 2009-10-28 2020-12-02 Valio Ltd Produit à base de protéines lactosériques et son procédé de préparation
WO2011078654A1 (fr) * 2009-12-24 2011-06-30 N.V. Nutricia Composition nutritionnelle hypocalorique riche en protéines destinée à la stimulation de la synthèse des protéines musculaires
EP2580967A1 (fr) 2011-10-11 2013-04-17 Nestec S.A. Accélération de récupération musculaire après une atrophie du muscle induite par l'immobilisation
ES2667705T3 (es) * 2013-11-15 2018-05-14 Grenade (Uk) Ltd Composiciones alimenticias

Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20010031729A1 (en) * 1999-12-30 2001-10-18 Van Loon Lucas J.C. Composition comprising carbohydrate and peptide material and its use as an energy supplement after or during physical exercise or as a metabolic nutrient for oral consumption
US6989171B2 (en) * 2001-04-02 2006-01-24 Pacifichealth Laboratories, Inc. Sports drink composition for enhancing glucose uptake into the muscle and extending endurance during physical exercise
US20060045906A1 (en) * 2004-08-25 2006-03-02 Gardiner Paul T Compositions and methods for activating protein synthesis and deactivating catabolic processes in skeletal muscle

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4780475A (en) * 1986-02-03 1988-10-25 Cerra Frank B Preparation for the prevention of catabolism
ES2007350A6 (es) * 1987-05-29 1989-06-16 Ganadera Union Ind Agro Productos alimenticios enriquecidos con nucleosidos yno nucleotidos para la nutricion infantil y de adultos, y procedimiento para su preparacion.
US5276018A (en) * 1992-07-17 1994-01-04 Brigham And Women's Hospital Composition comprising amino acids and methods for decreasing muscle breakdown
US6051236A (en) * 1998-11-12 2000-04-18 Pacifichealth Laboratories, Inc. Composition for optimizing muscle performance during exercise
US7008654B1 (en) * 1999-07-06 2006-03-07 Nestec S.A. Gelled nutritional composition and process

Patent Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20010031729A1 (en) * 1999-12-30 2001-10-18 Van Loon Lucas J.C. Composition comprising carbohydrate and peptide material and its use as an energy supplement after or during physical exercise or as a metabolic nutrient for oral consumption
US6989171B2 (en) * 2001-04-02 2006-01-24 Pacifichealth Laboratories, Inc. Sports drink composition for enhancing glucose uptake into the muscle and extending endurance during physical exercise
US20060045906A1 (en) * 2004-08-25 2006-03-02 Gardiner Paul T Compositions and methods for activating protein synthesis and deactivating catabolic processes in skeletal muscle

Also Published As

Publication number Publication date
WO2007143143A2 (fr) 2007-12-13
US20070280997A1 (en) 2007-12-06

Similar Documents

Publication Publication Date Title
WO2007143143A3 (fr) Composition servant à accroître la récupération musculaire
WO2008005862A3 (fr) Formulations enrichies pour bébé
WO2010146598A3 (fr) Vaccin de rotavirus sec et stable, compositions et procédé de préparation de ce dernier
EP1911453A3 (fr) Oligosaccharide immunémodulant
CO2022006972A2 (es) Composiciones que comprenden cepas bacterianas para uso en el aumento de la biodisponibilidad de aminoácidos derivados de proteínas
WO2008036932A3 (fr) Compositions et procédés utilisant l'espèce boswellia
WO2009076580A3 (fr) Compositions et procédés pour le traitement et la prévention de maladies cardiovasculaires
WO2009033768A3 (fr) Utilisation d'un peptide en tant qu'agent thérapeutique
WO2009043526A3 (fr) Utilisation d'un peptide en tant qu'agent thérapeutique
WO2008076579A3 (fr) Méthode de régulation du poids corporel chez des femmes présentant une carence estrogénique
UA97391C2 (ru) Лиофилизированный препарат, содержащий гриппозную вакцину, и способ его получения
Watanabe-Kamiyama et al. Antihypertensive effect of biotin in stroke-prone spontaneously hypertensive rats
WO2009033722A3 (fr) Utilisation d'un peptide comme agent thérapeutique
WO2009130181A3 (fr) Composition de transglutaminase sèche
KR100894365B1 (ko) 당뇨병 환자에서 심실 심근 기능을 개선하기 위한 분지쇄아미노산에 기초한 조성물
WO2005084440A8 (fr) Methode pouvant augmenter la masse musculaire et la force par administration d'adenosine triphosphate
WO2007006970A3 (fr) Produits alimentaires fermentes contenant des souches probiotiques, et leur procede de preparation
WO2009043469A3 (fr) Utilisation d'un peptide en tant qu'agent thérapeutique
US20040022913A1 (en) Natural sweetener
WO2009057280A1 (fr) Matière alimentaire renforçant les os
CN116456841A (zh) 果糖基转移酶的用途
CA2482199A1 (fr) Composition de rehydratation orale
WO2013173874A3 (fr) Composition et procédé pour prise en charge du diabète ou du pré-diabète
WO2006081320A3 (fr) Preparation pharmaceutique
WO2006118966A3 (fr) Formulations phosolipidiques et leurs utilisations dans la detection et le traitement de maladies pulmonaires

Legal Events

Date Code Title Description
121 Ep: the epo has been informed by wipo that ep was designated in this application

Ref document number: 07795650

Country of ref document: EP

Kind code of ref document: A2

122 Ep: pct application non-entry in european phase

Ref document number: 07795650

Country of ref document: EP

Kind code of ref document: A2